Pomdoctor Limited ADR (POM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,723 | -5,119 | 327,000 | 242,000 | -212,000 |
| Depreciation Amortization | 21 | 18 | 651,000 | 549,000 | 473,000 |
| Income taxes - deferred | N/A | N/A | 122,000 | 302,000 | 458,000 |
| Accounts receivable | -1,502 | 2,724 | -56,000 | 48,000 | -46,000 |
| Accounts payable and accrued liabilities | 2,785 | -2,239 | -14,000 | -22,000 | 1,000 |
| Other Working Capital | -5,416 | 2,402 | -90,000 | -315,000 | -536,000 |
| Other Operating Activity | 1,602 | 4 | -1,000 | 50,000 | 359,000 |
| Operating Cash Flow | $-21,232 | $-2,210 | $939,000 | $854,000 | $497,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -144 | -5 | -1,176,000 | -1,223,000 | -1,310,000 |
| Other Investing Activity | -86 | 0 | 15,000 | -3,000 | 899,000 |
| Investing Cash Flow | $-230 | $-5 | $-1,161,000 | $-1,226,000 | $-411,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 11,973 | 10,858 | 34,000 | 164,000 | -200,000 |
| Debt Issued | 1,001 | 822 | 858,000 | 766,000 | 1,050,000 |
| Debt Repayment | -160 | -170 | -420,000 | -434,000 | -1,008,000 |
| Common Stock Issued | N/A | N/A | 18,000 | 34,000 | 374,000 |
| Dividend Paid | 23,442 | N/A | -275,000 | -272,000 | -270,000 |
| Other Financing Activity | -14,245 | -9,179 | 18,000 | 105,000 | -34,000 |
| Financing Cash Flow | $22,011 | $2,331 | $233,000 | $363,000 | $-88,000 |
| Exchange Rate Effect | -273 | -1 | N/A | N/A | N/A |
| Beginning Cash Position | 1,094 | 932 | 14,000 | 23,000 | 25,000 |
| End Cash Position | 1,370 | 1,048 | 25,000 | 14,000 | 23,000 |
| Net Cash Flow | $276 | $116 | $11,000 | $-9,000 | $-2,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,232 | -2,210 | 939,000 | 854,000 | 497,000 |
| Capital Expenditure | -144 | -5 | -1,230,000 | -1,223,000 | -1,310,000 |
| Free Cash Flow | -21,376 | -2,215 | -291,000 | -369,000 | -813,000 |